Lilly rides Mounjaro, Zepbound to better
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street’s expectations even as it hustles to boost manufacturing and catch up to surging demand for the drugs.
Lilly said it was still dealing with supply issues that also hampered the company in the fourth quarter. Company officials expect that to persist through this year, but they emphasized Tuesday that help was on the way.
They expect significant manufacturing increases to occur, starting in the back half of the year.
CEO David Ricks told analysts Tuesday that Lilly was undergoing “the most ambitious expansion plan in our company’s history.”
Indianapolis-based Eli Lilly and Co. recorded $517 million in sales from Zepbound, which received approval from U.S. regulators last November. Total Mounjaro sales more than tripled to $1.81 billion from $568 million in last year’s quarter.
Related articles
Adams, Reyna, Turner, Ream are US concerns ahead of Copa America
NEW YORK (AP) — Tyler Adams, Gio Reyna, Matt Turner and Tim Ream will be given the three weeks ahead2024-05-21Chinese youngsters embrace more diversified tourism options
* China's tourism market is upgrading and becoming a strong source of economic growth. Neo-Chinese s2024-05-21China is source of growth and innovation: says Danone CEO
PARIS, May 15 (Xinhua) -- The thriving Sino-French relationship has been instrumental in Danone's su2024-05-21Miranda Lambert, 40, looks loved
Miranda Lambert and husband Brendan McLoughlin stole the spotlight at the 2024 Academy of Country Mu2024-05-21What a blast to work at NASA. Space agency is sky
WASHINGTON (AP) — Exploring the cosmos makes for happy employees, federal workers like to work from2024-05-21Thomas Detry's late birdie assured him of a top
LOUISVILLE, Ky. (AP) — Thomas Detry’s 12-footer for birdie on the par-5 18th on Sunday at the PGA Ch2024-05-21
atest comment